- Correction
- Open access
- Published:
Correction: Effect of chlorhexidine Mouthrinse on prevention of microbial contamination during EBUS-TBNA: a randomized controlled trial
BMC Cancer volume 23, Article number: 75 (2023)
The Original Article was published on 20 December 2022
Correction: BMC Cancer 22, 1334 (2022)
https://doi.org/10.1186/s12885-022-10442-5
Following publication of the original article [1], the authors reported errors in Figs. 2 and 3. The incorrect version of the figures were used. figuresThis correction article includes the updated versions of both figures.
Forest plots of subgroup analyses of colony forming unit counts in aerobic culture (A) and anaerobic culture (B)
Relative abundance of bacterial genera from needle wash samples. A total of 203 bacteria in the chlorhexidine mouthrinse group and 289 bacteria in the usual care group were identified by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. The dotted boxes represent the genera of oropharyngeal commensal bacteria
Further to this, the authors would like to correct the following:
1) “mouthrinse” in the article title should be in lowercase
2) Methods, Procedures, second paragraph: The sentence should read: "Following mediastinal evaluation using EBUS, TBNA was performed at the designated lymph nodes (LNs) or masses with a dedicated 22-gauge aspiration needle.", instead of "Following mediastinal evaluation using EBUS-TBNA was performed at the designated lymph nodes (LNs) or masses with a dedicated 22-gauge aspiration needle."
"EBUS-TBNA → EBUS, TBNA"
3) Results, Characteristics of participants and procedure, third paragraph: The sentence “Cytopathology examinations revealed that 24.5 and 17.9% of the LNs or masses were malignant in the chlorhexidine group and usual care group, respectively.” should be corrected to: “Cytopathology examinations revealed that 24.5% and 17.9% of the LNs or masses were malignant in the chlorhexidine group and usual care group, respectively.”
The '%' sign was omitted after the number 24.5.
"24.5 → 24.5%"
4) In the abbreviations section, the semicolon was duplicated before the entry “EUS-B-FNA”.
The original article [1] has been corrected.
Reference
Kim NY, Park JH, Park J, et al. Effect of chlorhexidine Mouthrinse on prevention of microbial contamination during EBUS-TBNA: a randomized controlled trial. BMC Cancer. 2022;22:1334. https://doi.org/10.1186/s12885-022-10442-5.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Kim, N.Y., Park, J.H., Park, J. et al. Correction: Effect of chlorhexidine Mouthrinse on prevention of microbial contamination during EBUS-TBNA: a randomized controlled trial. BMC Cancer 23, 75 (2023). https://doi.org/10.1186/s12885-023-10505-1
Published:
DOI: https://doi.org/10.1186/s12885-023-10505-1